Smoking Cessation Clinical Trial
— TTOPOfficial title:
Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
Smoking cessation has been shown to improve the effectiveness and reduce the morbidity of tobacco-related cancer treatments. We will identify effective smoking cessation strategies for patients who are receiving treatment for tobacco-related cancer. In this trial, patients' preferences in smoking cessation therapy will be the principal determinant by providers in developing a three component regimen of pharmaceutical therapy, counseling, and nicotine replacement therapy. This study will identify this cohort's preferences for smoking cessation strategies. We will then examine the impact of utilizing patient preferences upon cessation efficacy by directly comparing cessation success in this study with our recently completed study of the same population using the same tobacco treatments which were randomly assigned.
Status | Recruiting |
Enrollment | 126 |
Est. completion date | January 2026 |
Est. primary completion date | January 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - newly diagnosed or recurrent tobacco related malignancy - smoked at least 1 cigarette within 4 weeks of study enrollment - 10-pack year history of cigarette smoking - smoked at least 1 cigarette within 1 month of cancer diagnosis - life expectancy greater than 1 year Exclusion Criteria: - allergy to buproprion, varenicline and transdermal medicine - history of suicide attempt - hospitalized for psychiatric illness within past 2 years - history of active or uncontrolled eating disorder - uncontrolled epilepsy or seizure disorder - pregnant or lactating - within 3 months of myocardial infarction - unstable angina - uncontrolled hypertension - serious arrhythmia - history of taking varenicline or buproprion within one month of enrollment - concurrent enrollment in tobacco cessation therapy |
Country | Name | City | State |
---|---|---|---|
United States | Kings Daughters Medical Center - Ashland | Ashland | Kentucky |
United States | Med Center Health | Bowling Green | Kentucky |
United States | University Of Kentucky, Markey Cancer Center | Lexington | Kentucky |
United States | Owensboro Health Mitchell Memorial Cancer Center | Owensboro | Kentucky |
Lead Sponsor | Collaborator |
---|---|
Joseph Valentino, MD |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Number of patients requiring financial assistance with medication. | Number of patients requiring financial assistance with medication. | 6 months | |
Other | Number of patients with alteration in therapy | Number of patients with alteration in therapy due to ongoing cancer treatment. | 6 months | |
Other | Insurance coverage | Proportion of treatments covered by insurance/third party. | 6 months | |
Primary | Proportion of participants that quit smoking. | Proportion of participants that quit smoking at the 8 week assessment | at week 8 | |
Primary | Prevalence of cigarette use | Seven day point prevalence of cigarette use will be determined from participant reports and CO testing. | at week 8 | |
Secondary | Prevalence of cigarette use | Seven day point prevalence of cigarette use will be determined from participant reports and CO testing. | 6 months | |
Secondary | Preferred treatment | Proportion of participants preferring the treatment plan. | at baseline | |
Secondary | Change in Cigarette Use | Cigarette use will be recorded at weeks one, four, eight and at 6 months. | 6 months | |
Secondary | Drug Compliance | Subjects who complete 75% of the planned dosages of therapy will be considered compliant. | 6 months | |
Secondary | Counselling Compliance | Subjects who complete 60% of planned therapy sessions will be considered compliant. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT04617444 -
The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function
|
N/A | |
Completed |
NCT02796391 -
Facilitating Smoking Cessation With Reduced Nicotine Cigarettes
|
Phase 2 | |
Completed |
NCT03397511 -
Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City
|
N/A | |
Not yet recruiting |
NCT05188287 -
A Culturally Tailored Smartphone Application for African American Smokers
|
N/A | |
Recruiting |
NCT05264428 -
The Effect of Honey on Lessening the Withdrawal Symptoms
|
N/A | |
Recruiting |
NCT05846841 -
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
|
N/A | |
Completed |
NCT04133064 -
Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study
|
N/A | |
Completed |
NCT03187730 -
Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants
|
Phase 4 | |
Completed |
NCT03474783 -
To Explore the Factors Affecting the Effectiveness of Smoking Cessation
|
N/A | |
Completed |
NCT04635358 -
Feasibility Study of Smoking Cessation for the Staff of a Hospital Center
|
N/A | |
Terminated |
NCT03670264 -
BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation
|
N/A | |
Not yet recruiting |
NCT06307496 -
VIDeOS for Smoking Cessation
|
N/A | |
Completed |
NCT02997657 -
Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial
|
N/A | |
Completed |
NCT03206619 -
A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
|
||
Completed |
NCT02905656 -
Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit
|
N/A | |
Completed |
NCT02562521 -
A Smoking Cessation Intervention for Yale Dining Employees
|
Phase 4 | |
Completed |
NCT02239770 -
Pharmacokinetics of Nicotine Film in Smokers
|
N/A | |
Recruiting |
NCT02422914 -
Benefits of Tobacco Free Cigarette
|
N/A |